3WV-31942-14988
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 200 / DC
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
D9Y-23902-53439
Child or adolescent in my care · Male · 2022-07-02
V65-33611-83421
Child or adolescent in my care · Male · 2022-07-30
Timeline
-
2021-02-11
Registered in v-safe
-
2021-03-08
Dose 1 — Pfizer-BioNTech
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
-
2021-06-28
Survey response — 3 months, dose 2MedDRA: Fatigue, Nausea, Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fatigue and nausea due to early pregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-28
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-30
- 2021-07-01
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Be unable to work or attend schoolFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Survey response — 12 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Gave birth to a baby boy on (b)(6) · Healthcare visit (other): Gave birthMedDRA releases: 2024-11 · check-in free text available
-
2022-03-29
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-28 | Unsuccessful | |
| 2022-03-29 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Fatigue and nausea due to early pregnancy
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 11 — 12 months, dose 2
Symptoms: Gave birth to a baby boy on (b)(6)
Healthcare visit (other): Gave birth
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Delivery | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release